Remission in SLE—do DORIS criteria match the treating physician's judgment? A cross sectional study to assess reasons for discordance

Johanna Mucke, Christina Düsing, Nora Klose, Matthias Schneider, Gamal Chehab
2021 Rheumatology  
Objectives The definition of an accurate target for a treat to target (T2T) approach in systemic lupus erythematosus (SLE) has been challenging over the past years and recently the DORIS definitions of remission were presented by the international DORIS task force. It was our aim to assess the frequency of DORIS remission and LLDAS in our SLE-cohort and their agreement with the treating physician's (DORIS-) independent remission judgment. Patient characteristics leading to lack of agreement and
more » ... incoherence ought to be identified. Methods In this monocentric cross-sectional study patients with SLE were enrolled and assessed between September 2016 and December 2017. DORIS remission definitions were applied and after the clinical consultation, the treating physicians gave his opinion if his/her patient was in remission. Regression analyses were performed to identify parameters influencing physician remission. Results A total of 233 patients were included (87.6% female). 99 (42.5%) patients fulfilled any of the four DORIS remission definitions, while 126 patients were in remission according to their physician's judgement. We observed discordance in the assessment of remission in 53 patients (22.7%). Physician remission was influenced by both disease activity (OR 0.76 CI 0.63–9.90), disease and/or treatment related damage (OR 0.78, 0.62–0.98 and the presence of ds-DNA-antibodies 2.47 (1.06–6.04). Conclusions DORIS remission proved an achievable target in our outpatient clinic. Still we found discordance regarding DORIS remission and the treating physician's judgement with a greater number of patients considered in remission by their physicians.
doi:10.1093/rheumatology/keab005 pmid:33493321 fatcat:zhikjox7nbfrbpokpzlpijxpba